ClinicalTrials.Veeva

Menu

Medtronic 670G Insulin Pump and the Impact on Glycemic Control, Quality of Life, and Compliance

M

Metabolic Research Institute, Inc.

Status

Unknown

Conditions

Type 1 Diabetes Mellitus

Study type

Observational

Funder types

Other

Identifiers

NCT04329871
MetabolicRI

Details and patient eligibility

About

Analyze the Medtronic 670g pump on glycemic control

Full description

An Analysis of the Medtronic 670g Insulin pump use in clinical practice and the impact on glycemic control , quality of life, and compliance

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 18 or older
  • Documented History of Type 1 Diabetes Mellitus
  • 3 months continuous use of the Medtronic 670g pump system
  • given written informed consent

Exclusion criteria

  • Less than 3 months use of the Medtronic 670g pump system
  • Taking any other medication, other than the insulin used in the Medtronic 670g pump, to manage their diabetes
  • having medical conditions or taking medications that would preclude subject involvement or affect the outcomes being measured, in the opinion of the Investigator

Trial contacts and locations

1

Loading...

Central trial contact

Adriana Donadio; Paula M Dear

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems